Halia Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference
Lehi
•
May 28, 2026
•
2 Views
LEHI, Utah, May 28, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today announced that the Company will participate in the Jefferies 2026 Global Healthcare…
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
